CIK 1777015
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 49.10% | 45 |
| Health Care Equipment & Supplies | 31.81% | 24 |
| Life Sciences Tools & Services | 6.27% | 6 |
| Unclassified | 4.27% | 4 |
| Health Care Providers & Services | 2.93% | 6 |
| Food & Staples Retailing | 2.88% | 1 |
| Distributors | 1.14% | 1 |
| Software & IT Services | 1.11% | 1 |
| Commercial Services & Supplies | 0.47% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | SYK | STRYKER CORP | Health Care | 5.27% |
| 2 | DXCM | DEXCOM INC | Health Care | 4.49% |
| 3 | KALVISTA PHARMACEUTICALS INC | Unclassified | 3.83% | |
| 4 | PODD | INSULET CORP | Health Care | 3.41% |
| 5 | LLY | ELI LILLY & Co | Health Care | 3.30% |
| 6 | PTCT | PTC THERAPEUTICS, INC. | Health Care | 3.05% |
| 7 | XENE | Xenon Pharmaceuticals Inc. | Health Care | 3.00% |
| 8 | BSX | BOSTON SCIENTIFIC CORP | Health Care | 2.92% |
| 9 | CVS | CVS HEALTH Corp | Consumer Staples | 2.88% |
| 10 | RCUS | Arcus Biosciences, Inc. | Health Care | 2.70% |
85/89 names classified · sector 95.7% of weight · industry 95.7% · mkt cap 95.4%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 95.7% of the book is sector-classified (unclassified names shown, never dropped).
Classified: 51.4% of book weight (30/89 names) · unclassified 48.6%: , XENE, RCUS, LIVN, MBX, SNDX, QGEN, EYPT, AGIO, ASMB +49 more. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | SYKSTRYKER CORPORATION | 154,771 | $51M | 5.3% | ADD 47% |
| 2 | DXCMDEXCOM | 689,822 | $43M | 4.5% | ADD 17% |
| 3 | KALVISTA PHARMACEUTICALS INC | 1,835,506 | $37M | 3.8% | ADD 4% |
| 4 | PODDINSULET CORP | 156,561 | $33M | 3.4% | ADD 11% |
| 5 | LLYELI LILLY & CO | 34,616 | $32M | 3.3% | NEW |
| 6 | PTCTPTC THERAPEUTICS INC | 431,364 | $29M | 3.0% | ADD 169% |
| 7 | XENEXENON PHARMACEUTICALS INC | 497,035 | $29M | 3.0% | ADD 222% |
| 8 | BSXBOSTON SCIENTIFIC CORP | 448,768 | $28M | 2.9% | TRIM −10% |
| 9 | CVSCVS HEALTH CORP | 387,306 | $28M | 2.9% | TRIM −14% |
| 10 | RCUSARCUS BIOSCIENCES INC | 1,207,274 | $26M | 2.7% | ADD 25% |
| 11 | LIVNLIVANOVA PLC | 403,965 | $26M | 2.7% | HOLD |
| 12 | ZBHZIMMER BIOMET HOLDINGS INC | 269,557 | $24M | 2.5% | ADD 78% |
| 13 | MBXMBX BIOSCIENCES INC | 800,037 | $24M | 2.5% | TRIM −10% |
| 14 | ANIPANI PHARMACEUTICALS INC | 280,575 | $22M | 2.2% | ADD 94% |
| 15 | SNDXSYNDAX PHARMACEUTICALS INC | 901,511 | $21M | 2.2% | ADD 57% |
| 16 | QGENQIAGEN NV | 500,000 | $20M | 2.1% | NEW |
| 17 | NVSTENVISTA HOLDINGS CORPORATION | 711,693 | $18M | 1.9% | NEW |
| 18 | EYPTEYEPOINT INC | 1,354,800 | $17M | 1.8% | ADD 25% |
| 19 | ABBVABBVIE INC | 75,000 | $16M | 1.7% | NEW |
| 20 | BCRXBIOCRYST PHARMACEUTICALS INC | 1,708,099 | $16M | 1.7% | ADD 90% |
| 21 | IQVIQVIA HLDGS INC | 86,702 | $15M | 1.5% | ADD 146% |
| 22 | AGIOAGIOS PHARMACEUTICALS INC | 403,525 | $14M | 1.4% | ADD 305% |
| 23 | ILMNILLUMINA INC | 110,370 | $14M | 1.4% | NEW |
| 24 | EWEDWARDS LIFESCIENCES CORP | 167,155 | $13M | 1.4% | ADD 11% |
| 25 | NBIXNEUROCRINE BIOSCIENCES INC | 99,069 | $13M | 1.4% | TRIM −14% |
| 26 | KNSAKINIKSA PHARMACEUTICALS INTL | 259,184 | $12M | 1.3% | TRIM −61% |
| 27 | ASMBASSEMBLY BIOSCIENCES INC | 411,227 | $11M | 1.2% | ADD 65% |
| 28 | GPCRSTRUCTURE THERAPEUTICS INC | 232,093 | $11M | 1.2% | ADD 322% |
| 29 | MCKMCKESSON CORP | 12,676 | $11M | 1.1% | TRIM −65% |
| 30 | STOKSTOKE THERAPEUTICS INC | 336,519 | $11M | 1.1% | TRIM −22% |
| 31 | VRDNVIRIDIAN THERAPEUTICS INC | 557,936 | $11M | 1.1% | TRIM −29% |
| 32 | WAYWAYSTAR HLDG CORP | 443,058 | $11M | 1.1% | ADD 20% |
| 33 | MLYSMINERALYS THERAPEUTICS INC | 380,137 | $10M | 1.1% | TRIM −7% |
| 34 | EWTXEDGEWISE THERAPEUTICS INC | 322,828 | $10M | 1.1% | TRIM −25% |
| 35 | XERSXERIS BIOPHARMA HOLDINGS INC | 1,721,264 | $10M | 1.0% | HOLD |
| 36 | THCTenet Healthcare Corp. | 50,123 | $9M | 1.0% | TRIM −17% |
| 37 | AORTARTIVION INC | 252,014 | $9M | 1.0% | ADD 15% |
| 38 | NUVLNUVALENT INC | 88,078 | $9M | 0.9% | TRIM −26% |
| 39 | ATECALPHATEC HLDGS INC | 823,763 | $9M | 0.9% | ADD 197% |
| 40 | ALNYALNYLAM PHARMACEUTICALS INC | 26,916 | $9M | 0.9% | TRIM −44% |
| 41 | AXGNAXOGEN INC | 268,160 | $9M | 0.9% | ADD 7% |
| 42 | IMNMIMMUNOME INC | 403,487 | $9M | 0.9% | ADD 45% |
| 43 | AMLXAMYLYX PHARMACEUTICALS INC | 621,458 | $9M | 0.9% | ADD 63% |
| 44 | IDXXIDEXX LABS INC | 15,000 | $8M | 0.9% | NEW |
| 45 | WATWATERS CORP | 26,447 | $8M | 0.8% | TRIM −37% |
| 46 | ADPTADAPTIVE BIOTECHNOLOGIES COR | 551,815 | $8M | 0.8% | ADD 37% |
| 47 | UPBUPSTREAM BIO INC | 786,783 | $7M | 0.7% | TRIM −6% |
| 48 | ERASERASCA INC | 406,702 | $7M | 0.7% | NEW |
| 49 | APGEAPOGEE THERAPEUTICS INC | 77,686 | $7M | 0.7% | TRIM −40% |
| 50 | COOCOOPER COS INC | 89,883 | $6M | 0.7% | TRIM −28% |
| 51 | ABSIABSCI CORPORATION | 1,864,806 | $6M | 0.6% | ADD 28% |
| 52 | TNGXTANGO THERAPEUTICS INC | 266,127 | $6M | 0.6% | NEW |
| 53 | CDNACAREDX INC | 291,378 | $5M | 0.5% | ADD 6% |
| 54 | URGNUROGEN PHARMA LTD | 275,000 | $5M | 0.5% | ADD 63% |
| 55 | RAREULTRAGENYX PHARMACEUTICAL IN | 235,000 | $5M | 0.5% | ADD 279% |
| 56 | FDMT4D MOLECULAR THERAPEUTICS IN | 522,577 | $5M | 0.5% | ADD 4% |
| 57 | IRTCIRHYTHM HOLDINGS INC | 40,125 | $5M | 0.5% | NEW |
| 58 | MMEDMINIMED GROUP INC | 317,324 | $5M | 0.5% | NEW |
| 59 | SIBNSI-BONE INC | 373,553 | $5M | 0.5% | HOLD |
| 60 | CARLCARLSMED INC | 521,123 | $5M | 0.5% | NEW |
| 61 | OPRXOPTIMIZERX CORP | 729,369 | $5M | 0.5% | ADD 35% |
| 62 | VIRVIR BIOTECHNOLOGY INC | 500,000 | $4M | 0.5% | NEW |
| 63 | SUPNSUPERNUS PHARMACEUTICALS INC | 85,062 | $4M | 0.5% | NEW |
| 64 | CAICARIS LIFE SCIENCES INC | 229,912 | $4M | 0.4% | ADD 84% |
| 65 | CVRXCVRX INC | 429,507 | $4M | 0.4% | ADD 4% |
| 66 | NSPRINSPIREMD INC | 2,416,518 | $4M | 0.4% | HOLD |
| 67 | COGTCOGENT BIOSCIENCES INC | 100,126 | $4M | 0.4% | NEW |
| 68 | AMRXAMNEAL PHARMACEUTICALS INC | 300,752 | $4M | 0.4% | NEW |
| 69 | ANNXANNEXON INC | 674,013 | $4M | 0.4% | ADD 12% |
| 70 | ALGNALIGN TECHNOLOGY INC | 21,233 | $4M | 0.4% | TRIM −16% |
| 71 | QUREUNIQURE NV | 206,842 | $3M | 0.4% | TRIM −20% |
| 72 | WGSGENEDX HOLDINGS CORP | 50,778 | $3M | 0.3% | ADD 29% |
| 73 | VCYTVERACYTE INC | 101,237 | $3M | 0.3% | HOLD |
| 74 | CSTLCASTLE BIOSCIENCES INC | 126,150 | $3M | 0.3% | TRIM −16% |
| 75 | CMPSCOMPASS PATHWAYS PLC | 554,411 | $3M | 0.3% | ADD 457% |
| 76 | DRUGBRIGHT MINDS BIOSCIENCES INC | 40,098 | $3M | 0.3% | NEW |
| 77 | SLDBSOLID BIOSCIENCES INC | 308,844 | $2M | 0.2% | TRIM −26% |
| 78 | BFLYBUTTERFLY NETWORK INC | 544,477 | $2M | 0.2% | ADD 440% |
| 79 | QDELQUIDELORTHO CORP | 101,764 | $2M | 0.2% | TRIM −45% |
| 80 | RXSTRXSIGHT INC | 249,989 | $2M | 0.2% | TRIM −29% |
| 81 | QTRXQUANTERIX CORP | 341,453 | $1M | 0.1% | ADD 4% |
| 82 | PLSEPULSE BIOSCIENCES INC | 50,125 | $1M | 0.1% | NEW |
| 83 | LUNGPULMONX CORP | 755,636 | $974,770 | 0.1% | ADD 4% |
| 84 | MAZEMAZE THERAPEUTICS INC | 31,844 | $950,543 | 0.1% | TRIM −85% |
| 85 | ADMAADMA BIOLOGICS INC | 82,443 | $742,811 | 0.1% | TRIM −59% |
| 86 | FOCLEDAP TMS S A | 154,832 | $575,975 | 0.1% | HOLD |
| 87 | OVIDOVID THERAPEUTICS INC | 208,205 | $462,215 | 0.0% | ADD 4% |
| 88 | ARAYACCURAY INC | 884,578 | $343,305 | 0.0% | ADD 4% |
| 89 | ENTXENTERA BIO LTD | 288,670 | $320,424 | 0.0% | ADD 5% |
| Security | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| SYKSTRYKER CORPORATION | 78K | 78K | 50K | 64K | 105K | 155K | $51M |
| DXCMDEXCOM | 79K | 130K | 226K | 172K | 587K | 690K | $43M |
| KALVISTA PHARMACEUTICALS INC | — | 754K | 679K | 1.7M | 1.8M | 1.8M | $37M |
| PODDINSULET CORP | 126K | 131K | 106K | 116K | 141K | 157K | $33M |
| LLYELI LILLY & CO | 28K | 39K | 33K | 10K | — | 35K | $32M |
| PTCTPTC THERAPEUTICS INC | 177K | 280K | 182K | 202K | 160K | 431K | $29M |
| XENEXENON PHARMACEUTICALS INC | 193K | 175K | 150K | 176K | 154K | 497K | $29M |
| BSXBOSTON SCIENTIFIC CORP | 337K | 226K | 283K | 434K | 501K | 449K | $28M |
| CVSCVS HEALTH CORP | 180K | 497K | 518K | 379K | 450K | 387K | $28M |
| RCUSARCUS BIOSCIENCES INC | 1.3M | 1.2M | 600K | 653K | 969K | 1.2M | $26M |
| LIVNLIVANOVA PLC | 175K | 167K | 175K | 276K | 411K | 404K | $26M |
| ZBHZIMMER BIOMET HOLDINGS INC | — | 201K | 240K | 251K | 151K | 270K | $24M |
| MBXMBX BIOSCIENCES INC | 170K | 328K | 872K | 773K | 886K | 800K | $24M |
| ANIPANI PHARMACEUTICALS INC | — | 105K | 128K | — | 145K | 281K | $22M |
| SNDXSYNDAX PHARMACEUTICALS INC | 527K | 595K | 868K | 847K | 574K | 902K | $21M |
Shares reported each quarter by the largest current holdings. Green = added vs the prior filing of that name, red = trimmed, grey = roughly held; a dash is a quarter with no 13F on file (a gap is skipped, not read as an exit). 13F is filed up to 45 days after quarter-end. Up to 40 quarters (10 years) available — use the selector above.
Where this firm's principals came from and which firms its alumni went on to found.
